Principali pubblicazioni in campo internazionale (ultimi anni)

• C. Pulito, F. Mori, A. Sacconi, F. Goeman, M. Ferraiuolo, P. Pasanisi, C. Campagnoli, F. Berrino et al. CELL DISCOVERY 3, 17022, 2017
• C. Campagnoli, P. Pasanisi, I. Castellano, C. Abbà, T. Brucato, F. Berrino. POSTMENOPAUSAL BREAST CANCER, ANDROGENS AND AROMATASE INHIBITORS. Breast Cancer Res Treat, 139, 1, 2013.
• C. Campagnoli, F. Berrino, E. Venturelli, C. Abbà, N. Biglia, T. Brucato, P. Cogliati et al. METFORMIN DECREASES CIRCULATING ANDROGEN AND ESTROGEN LEVELS IN NON-DIABETIC WOMEN WITH BREAST CANCER. Clinical Breast Cancer, 13, 433, 2013.
• C. Campagnoli, C. Abbà, S. Ambroggio, T. Brucato, P. Pasanisi. LIFE-STYLE AND METFORMIN FOR THE PREVENTION OF ENDOMETRIAL PATHOLOGY IN POST-MENOPAUSAL WOMEN. Gynecol. Endocrinol., 29, 119, 2013.
• G. Abbate Daga, S. Campisi, E. Marzola, G. Rocca, C. Peris, C. Campagnoli et al. AMENORRHEA IN EATING DISORDERS: POOR STABILITY OF SYMPTOM AFTER A ONE-YEAR TREATMENT. Eat Weight Disord., 17, e78, 2012.
• C. Campagnoli, P. Pasanisi, C. Abbà, S. Ambroggio, N. Biglia, T. Brucato, R. Colombero et al. EFFECT OF DIFFERENT DOSES OF METFORMIN ON SERUM TESTOSTERONE AND INSULIN IN NON-DIABETIC WOMEN WITH BREAST CANCER: A RANDOMIZED STUDY. Clinical Breast Cancer, 12, 175, 2012.
• C. Campagnoli, S. Ambroggio, M.R. Lotano, C. Peris. PROGESTOGEN USE IN WOMEN APPROACHING THE MENOPAUSE AND BREAST CANCER RISK. Maturitas 62, 338, 2009.
• A.E. Schindler, C. Campagnoli, R. Druckmann, J. Huber, J.R. Pasqualini, K.W. Schweppe, J.H. Thijssen. REPRINT OF: CLASSIFICATION AND PHARMACOLOGY OF PROGESTINS. Maturitas, 61, 171, 2008.
• C. Campagnoli, P. Pasanisi, C. Peris, F. Berrino. INSULIN-LIKE GROWTH FACTOR-I AND BREAST CANCER: EPIDEMIOLOGICAL AND CLINICAL DATA. In J.R. Pasqualini ed. “Breast cancer: prognosis, treatment and prevention”, 2nd ed. New York: Informa Healthcare, 323, 2008.
• C. Campagnoli, C. Abbà, S. Ambroggio M.R. Lotano, C. Peris. DIFFERENTIAL EFFECTS OF VARIOUS PROGESTOGENS ON THE METABOLIC RISK FACTORS FOR BREAST CANCER. Gynecol. Endocrinol., 23 (S1), 22, 2007.
• C. Campagnoli, C. Abbà, S. Ambroggio, C. Peris. PREGNANCY, PROGESTERONE AND PROGESTINS IN RELATION TO BREAST CANCER RISK. J. Steroid. Biochem. Mol. Biol., 97, 441, 2005.
• C. Campagnoli, C. Abbà, S. Ambroggio, C. Peris, M. Perona, P. Sanseverino. POLYUNSATURED FATTY ACIDS (PUFAs) MIGHT REDUCE HOT FLUSHES: AN INDICATION FROM TWO CONTROLLED TRIALS ON SOY ISOFLAVONES ALONE AND WITH A PUFA SUPPLEMENT. Maturitas, 51, 127, 2005.
• C. Campagnoli, F. Clavel-Chapelon, R. Kaaks, C. Peris, F. Berrino. PROGESTINS AND PROGESTERONE IN HORMONE REPLACEMENT THERAPY AND THE RISK OF BREAST CANCER. J Steroid. Biochem. Mol. Biol, 96, 95, 2005.
• C. Campagnoli, C. Abbà, S. Ambroggio, C. Peris. EFFECT OF ESTROGEN-ONLY TREATMENT IN POSTMENOPAUSAL WOMEN (letter). JAMA, 292, 684, author reply 685, 2004.
• C. Campagnoli, C. Abbà, S. Ambroggio, C. Peris. DIFFERENTIAL EFFECTS OF PROGESTINS ON THE CIRCULATING IGF-I SYSTEM. Maturitas, 10, S39, 2003.
• C. Campagnoli, S. Ambroggio, P. Belforte, M.G. Lanza, M.R. Lotano, C. Peris. THE LONG-TERM ESTROGEN PROGESTIN THERAPY IN SUBJECTS WITH HYPERGONADOTROPIC STATES. In V. Bruni, M. Dei eds. “Pediatric and adolescent gynecology”, 522 CIC Edizioni Internazionali, Rome, 2003.
• A.E. Schindler, C. Campagnoli, R. Druckmann, J. Huber, J.R. Pasqualini, K. W. Schweppe, J.H. Thijssen. CLASSIFICATION AND PHARMACOLOGY OF PROGESTINS. Maturitas, 10, S7- 2003.
• C. Campagnoli, P. Colombo, D. De Aloysio, et al. POSITIVE EFFECTS ON CARDIOVASCULAR AND BREAST METABOLIC MARKERS OF ORAL ESTRADIOL AND DYDROGESTERONE IN COMPARISON WITH TRANSDERMAL ESTRADIOL AND NORETHISTERONE ACETATE. Maturitas, 41, 299, 2002.
• C. Campagnoli, C. Abbà, S. Ambroggio, N. Biglia, R. Ponzone. BREAST CANCER AND HORMONE REPLACEMENT THERAPY: PUTTING THE RISK INTO PERSPECTIVE. Gynecol. Endocrinol., 15 (Suppl 6), 53, 2001.
• C. Campagnoli, F. Altare, C. Buzio, P. Sanseverino. EFFECT OF CONJUGATED ESTROGENS ON FREE IGF-I? (letter) Fertil. Steril., 76, 640, 2001.
• S. Adami, V. Bruni, D. Bianchini, A. Becorpi, P. Lombardi, C. Campagnoli, et al. PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS WITH CYCLICAL ETIDRONATE. J. Endocrinol. Invest., 23, 310, 2000.
• J.C. Huber, C. Campagnoli, R. Druckmann, C. Ebert, J.R. Pasqualini, J. Ruby, K.W. Schweppe, A.E. Schindler, J.H.H. Thijssen. RECOMMENDATIONS FOR ESTROGEN AND PROGESTIN REPLACEMENT IN THE CLIMACTERIC AND POSTMENOPAUSE. Maturitas, 33, 197, 1999.
• C. Campagnoli, S. Ambroggio, N. Biglia, P. Sismondi. CONJUGATED ESTROGENS AND BREAST CANCER RISK. Gynecol. Endocrinol., 13 (Suppl 6), 13, 1999.
• C. Campagnoli, N. Biglia, C. Cantamessa, L. Lesca, P. Sismondi. HRT AND BREAST CANCER RISK: A CLUE FOR INTERPRETING THE AVAILABLE DATA. Maturitas, 33, 185, 1999.
• C. Campagnoli, N. Biglia, C. Cantamessa L. Lesca, M. R. Lotano, P. Sismondi. INSULIN-LIKE GROWTH FACTOR I (IGF-I) SERUM LEVEL MODIFICATIONS DURING TRANSDERMAL ESTRADIOL TREATMENT IN POSTMENOPAUSAL WOMEN: A POSSIBLE BIMODAL EFFECT DEPENDING ON BASAL IGF-I VALUES. Gynecol. Endocrinol., 12, 259, 1998.
• C. Campagnoli, S. Ambroggio, N. Biglia, C. Peris, P. Sismondi (INSULIN-LIKE GROWTH FACTOR I), HORMONE REPLACEMENT THERAPY AND BREAST CANCER RISK (letter). Lancet 352, 488, 1998.
• A.E. Schindler, C. Campagnoli, R. Druckmann, J. Huber, J.R. Pasqualini, K.W. Schweppe, J.H.H. Thijssen. ASPECTS OF PROGESTIN ACTIVITY ON THE BREAST. Maturitas 29, 61, 1998.
• C. Campagnoli, N. Biglia, M. Giai, P. Sismondi. PROGESTINS AND BREAST CANCER RISK. Zentralbl. Gynakol. 119, 38, 1997.
• C. Campagnoli, N. Biglia, C. Cantamessa, M. M. Di Sario, L. Lesca. EFFECT OF PROGESTINS ON IGF-I SERUM LEVEL IN ESTROGEN-TREATED POSTMENOPAUSAL WOMEN. Zentralbl. Gynakol. 119, 7, 1997.
• C. Campagnoli, P. Belforte, M. M. Di Sario, L. Lesca. LIPID PROFILE DURING HORMONE REPLACEMENT THERAPY: EFFECT OF DIFFERENT PROGESTINS. Zentralbl. Gynakol. 119, 1, 1997.
• C. Campagnoli, R. Druckmann, J. Huber, J.R. Pasqualini, K.W. Schweppe, J.H.H. Thijssen, A.E. Schindler. PROGESTINS: PRESENT AND FUTURE. J. Steroid Biochem. Molec. Biol. 59, 357, 1996.